Drug Therapy

Contributing journals to this collection:
JAMA & Archives Journals

Citations 101-110 of 3664 total displayed.

Past content

Controversies
Contact Lens Solutions: Part of the Problem

Elisabeth J. Cohen
Arch Ophthalmol 2009; 127: 1544-1546. [Extract] [Full text] [PDF]  

Research Letters
Intracisternal Irrigation of Papaverine Leading to Choroidal Infarction

Shantan Reddy; Darin R. Goldman; Andrew Kaines; Jean-Pierre Hubschman; David Sarraf
Arch Ophthalmol 2009; 127: 1550-1551. [Extract] [Full text] [PDF]  

Medical News & Perspectives
FDA Steps Up Efforts to Find, Remove Violators of Clinical Trial Regulations

Bridget M. Kuehn
JAMA 2009; 302: 1739-1741. [Extract] [Full text] [PDF]  

Letters
Obesity and Survival Among Patients With Pancreatic Cancer—Reply

Donghui Li; Manal M. Hassan; James L. Abbruzzese
JAMA 2009; 302: 1752-a-1753-a. [Extract] [Full text] [PDF]  

Letters
Obesity and Survival Among Patients With Pancreatic Cancer

Mark R. Goldstein; Luca Mascitelli; Francesca Pezzetta
JAMA 2009; 302: 1752. [Extract] [Full text] [PDF]  

Research Letters
Cost-Related Medication Nonadherence After Implementation of Medicare Part D, 2006-2007

Jeanne M. Madden; Amy J. Graves; Dennis Ross-Degnan; Becky A. Briesacher; Stephen B. Soumerai
JAMA 2009; 302: 1755-1756. [Extract] [Full text] [PDF]  

Original Contributions
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

Christoph U. Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M. Kane; Anil K. Malhotra
JAMA 2009; 302: 1765-1773. [Abstract] [Full text] [PDF] [ eTables ]  

Editorials
Implications of Marked Weight Gain Associated With Atypical Antipsychotic Medications in Children and Adolescents

Christopher K. Varley; Jon McClellan
JAMA 2009; 302: 1811-1812. [Extract] [Full text] [PDF]  

Editorials
Adverse Events in Randomized Trials: Neglected, Restricted, Distorted, and Silenced

John P. A. Ioannidis
Arch Intern Med 2009; 169: 1737-1739. [Extract] [Full text] [PDF]  

Commentaries
Going Off-label Without Venturing Off-Course: Evidence and Ethical Off-label Prescribing

Emily A. Largent; Franklin G. Miller; Steven D. Pearson
Arch Intern Med 2009; 169: 1745-1747. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367